Evidence map›Paper›PMID 40386925›Full record

ArticleJournal of medical imaging and radiation oncology2025

MRI Signatures of Parotid Tumours Impacting Management Decisions: A Retrospective Study With Radiology and Pathology Correlation.

Nivedita Chakrabarty, Prathamesh Pai, Arpita Sahu, Oindrila Roy Chowdhury, Pashmina Kandalgaonkar, Tapish Dadlani, Munita Menon, Suman Kumar Ankathi

Abstract read
In one paragraph

Article in Journal of medical imaging and radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nivedita ChakrabartyDepartment of Radiodiagnosis, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra, India.ORCID https://orcid.org/0000-0003-4569-0693
Prathamesh PaiDepartment of Surgical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel Mumbai, Maharashtra, India.
Arpita SahuDepartment of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra, India.ORCID https://orcid.org/0000-0003-1549-3680
Oindrila Roy ChowdhuryDepartment of CRS, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Pashmina KandalgaonkarDepartment of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra, India.
Tapish DadlaniDepartment of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra, India.
Munita MenonDepartment of Pathology, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra, India.
Suman Kumar AnkathiDepartment of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFine needle aspiration (FNA) from parotid tumour is inadequate and nondiagnostic in 8% and FNA/biopsy from deep lobe is technically challenging; hence, our first objective was to evaluate MRI findings which best predict the benign and malignant nature of parotid tumour. Our second objective was to develop MRI signatures for parotid tumour histopathologies including grades of carcinoma, to help in decision making regarding elective neck dissection.

methodsTwo head and neck radiologists retrospectively evaluated and developed signatures of common benign and malignant parotid tumours using morphology and signal intensity-related variables for 98 patients on MRI available in PACS from 01 January 2016 to 26 December 2022. T1 weighted image (WI), T2WI, short tau inversion recovery, diffusion WI/apparent diffusion coefficient and postcontrast T1WI sequences were evaluated. The developed MRI signatures were then validated by a blinded third radiologist.

resultsSensitivity, specificity, accuracy, positive and negative predictive values using MRI signatures were 92.31%, 100%, 94.23%, 100% and 81.25%, respectively, for benign and malignant nature of parotid tumours with a highly significant p-value (< 1e-04). Developed MRI signatures also showed high statistical performance and significant p-value for parotid tumour histopathologies and grades of mucoepidermoid carcinoma (MEC). T2 signal intensity and enhancement patterns can help identify low-grade MEC, impacting management decisions regarding elective neck dissection.

conclusionsMRI can predict the benign and malignant nature, parotid tumour histopathologies and grades of MEC when typical signatures are present, impacting management decisions.

Indexed as

Magnetic Resonance ImagingParotid NeoplasmsAdolescentAdultAgedAged, 80 and overClinical Decision-MakingFemaleHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityYoung Adultbenign and malignant parotid tumoursgrades of mucoepidermoid carcinomaMRI of parotid tumours

Identifiers

PMID40386925
PMCPMC12175207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.